Duality of liver and kidney lesions after systemic infection of immunosuppressed and immunocompetent mice with Aspergillus fumigatus

Virulence

Volumn 3, Issue 1, 2012, Pages 43-50

  Jouvion, Grégory ^a,b   Brock, Matthias ^c   Droin Bergère, Sabrina ^a,b   Ibrahim Granet, Oumaïma ^a  

^a INSTITUT PASTEUR   (France)

^b LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^c HANS KNÖLL INSTITUTE   (Germany)

Author keywords

Bioluminescence imaging; Histology; Immunosuppression; Invasive aspergillosis

Indexed keywords

CORTISONE ACETATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; BIOLUMINESCENCE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; FUNGAL STRAIN; FUNGUS GROWTH; HEPATITIS; IMMUNE DEFICIENCY; IMMUNOCOMPETENCE; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATORY DISEASE; KIDNEY INFECTION; MALE; MOUSE; NONHUMAN; ANIMAL; BAGG ALBINO MOUSE; COMPARATIVE STUDY; HUMAN; IMMUNOCOMPROMISED PATIENT; IMMUNOLOGY; KIDNEY; LIVER; MICROBIOLOGY; PHYSIOLOGY;

ASPERGILLUS FUMIGATUS; MUS;

ANIMALS; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; HUMANS; IMMUNOCOMPROMISED HOST; KIDNEY; LIVER; MALE; MICE; MICE, INBRED BALB C;

EID: 84858229446     PISSN: 21505594     EISSN: 21505608     Source Type: Journal    
DOI: 10.4161/viru.3.1.18654     Document Type: Article

References (25)

1. Alderson JW, Van Dinter TG, Jr., Opatowsky MJ, Burton EC. Disseminated aspergillosis following infliximab therapy in an immunosuppressed patient with Crohn's disease and chronic hepatitis C: a case study and review of the literature. MedGenMed 2005; 7:7; PMID:16369233
2. Bartlett JG. Aspergillosis update. Medicine (Baltimore) 2000; 79:281-282; PMID:10941357; http://dx.doi.org/10.1097/00005792-200007000-00009
3. Eggimann P, Chevrolet JC, Starobinski M, Majno P, Totsch M, Chapuis B, et al. Primary invasive aspergillosis of the digestive tract: report of two cases and review of the literature. Infection 2006; 34:333-338; PMID:17180588; http://dx.doi.org/10.1007/s15010-006-5660-0
4. Ibrahim-Granet O, Jouvion G, Hohl TM, Droin-Bergere S, Philippart F, Kim OY, et al. In vivo bioluminescence imaging and histopathopathologic analysis reveal distinct roles for resident and recruited immune effector cells in defense against invasive aspergillosis. BMC Microbiol 2010; 10:105; PMID:20377900; http://dx.doi.org/10.1186/1471-2180-10-105
5. Mavridou E, Bruggemann RJ, Melchers WJ, Verweij PE, Mouton JW. Impact of cyp51A mutations on the pharmacokinetic and pharmacodynamic properties of voriconazole in a murine model of disseminated aspergillosis. Antimicrob Agents Chemother 2010; 54:4758-4764; PMID:20733046; http://dx.doi.org/10.1128/AAC.00606-10
6. Olson JA, George A, Constable D, Smith P, Proffitt RT, Adler-Moore JP. Liposomal amphotericin B and echinocandins as monotherapy or sequential or concomitant therapy in murine disseminated and pulmonary Aspergillus fumigatus infections. Antimicrob Agents Chemother 2010; 54:3884-3894; PMID:20606065; http://dx.doi.org/10.1128/AAC.01554-09
7. Clemons KV, Stevens DA. The contribution of animal models of aspergillosis to understanding pathogenesis, therapy and virulence. Med Mycol 2005; 43(Suppl 1): S101-S110; PMID:16110800; http://dx.doi.org/10.1080/13693780500051919
8. Kretschmar M, Buchheidt D, Hof H, Nichterlein T. Galactomannan enzyme immunoassay for monitoring systemic infection with Aspergillus fumigatus in mice. Diagn Microbiol Infect Dis 2001; 41:107-112; PMID: 11750162; http://dx.doi.org/10.1016/S0732-8893(01)00282-6
9. Vallor AC, Kirkpatrick WR, Najvar LK, Bocanegra R, Kinney MC, Fothergill AW, et al. Assessment of Aspergillus fumigatus burden in pulmonary tissue of guinea pigs by quantitative PCR, galactomannan enzyme immunoassay, and quantitative culture. Antimicrob Agents Chemother 2008; 52:2593-2598; PMID:18474582; http://dx.doi.org/10.1128/AAC.00276-08
10. Brock M, Jouvion G, Droin-Bergere S, Dussurget O, Nicola MA, Ibrahim-Granet O. Bioluminescent Aspergillus fumigatus, a new tool for drug efficiency testing and in vivo monitoring of invasive aspergillosis. Appl Environ Microbiol 2008; 74:7023-7035; PMID:18820063; http://dx.doi.org/10.1128/AEM.01288-08
11. Schöbel F, Ibrahim-Granet O, Ave P, Latge JP, Brakhage AA, Brock M. Aspergillus fumigatus does not require fatty acid metabolism via isocitrate lyase for development of invasive aspergillosis. Infect Immun 2007; 75:1237-1244; PMID:17178786; http://dx.doi.org/10.1128/IAI.01416-06
12. Sinha BK, Monga DP, Prasad S. A combination of Gomori-Grocott methenamine silver nitrate and hematoxylene and eosin staining technique for the demonstration of Candida albicans in tissue. Quad Sclavo Diagn 1988; 24:129-132; PMID:2479048
13. Walsh TJ, Anaissie EJ, Denning DW, Herbrecht R, Kontoyiannis DP, Marr KA, et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46:327-360; PMID:18177225; http://dx.doi.org/10.1086/525258
14. Clemons KV, Parmar R, Martinez M, Stevens DA. Efficacy of Abelcet alone, or in combination therapy, against experimental central nervous system aspergillosis. J Antimicrob Chemother 2006; 58:466-469; PMID:16760192; http://dx.doi.org/10.1093/jac/dkl236
15. Berger F, Paulmurugan R, Bhaumik S, Gambhir SS. Uptake kinetics and biodistribution of 14C-D-luciferin-a radiolabeled substrate for the firefly luciferase catalyzed bioluminescence reaction: impact on bioluminescence based reporter gene imaging. Eur J Nucl Med Mol Imaging 2008; 35:2275-2285; PMID:18661130; http://dx.doi.org/10.1007/s00259-008-0870-6
16. Lee KH, Byun SS, Paik JY, Lee SY, Song SH, Choe YS, et al. Cell uptake and tissue distribution of radioiodine labelled D-luciferin: implications for luciferase based gene imaging. Nucl Med Commun 2003; 24: 1003-1009; PMID:12960600; http://dx.doi.org/10.1097/00006231-200309000-00009
17. Parker GA, Picut CA. Liver immunobiology. Toxicol Pathol 2005; 33:52-62; PMID:15805056; http://dx.doi.org/10.1080/01926230590522365
18. Overland G, Stuestol JF, Dahle MK, Myhre AE, Netea MG, Verweij P, et al. Cytokine responses to fungal pathogens in Kupffer Cells are Toll-like receptor 4 independent and mediated by tyrosine kinases. Scand J Immunol 2005; 62:148-154; PMID:16101821; http://dx.doi.org/10.1111/j.1365-3083.2005.01653.x
19. Lim HY, Muller N, Herold MJ, van den Brandt J, Reichardt HM. Glucocorticoids exert opposing effects on macrophage function dependent on their concentration. Immunology 2007; 122:47-53; PMID:17451463; http://dx.doi.org/10.1111/j.1365-2567.2007.02611.x
20. Schleimer RP. Glucocorticoids suppress inflammation but spare innate immune responses in airway epithelium. Proc Am Thorac Soc 2004; 1:222-230; PMID:16113438; http://dx.doi.org/10.1513/pats.200402-018MS
21. Krueger PD, Lassen MG, Qiao H, Hahn YS. Regulation of NK cell repertoire and function in the liver. Crit Rev Immunol 2011; 31:43-52; PMID:21395510
22. Andreu N, Zelmer A, Wiles S. Noninvasive biophotonic imaging for studies of infectious disease. FEMS Microbiol Rev 2011; 35:360-394; PMID:20955395; http://dx.doi.org/10.1111/j.1574-6976.2010.00252.x
23. Doyle TC, Nawotka KA, Kawahara CB, Francis KP, Contag PR. Visualizing fungal infections in living mice using bioluminescent pathogenic Candida albicans strains transformed with the firefly luciferase gene. Microb Pathog 2006; 40:82-90; PMID:16426810; http://dx.doi.org/10.1016/j.micpath.2005.11.003
24. Enjalbert B, Rachini A, Vediyappan G, Pietrella D, Spaccapelo R, Vecchiarelli A, et al. A multifunctional, synthetic Gaussia princeps luciferase reporter for live imaging of Candida albicans infections. Infect Immun 2009; 77:4847-4858; PMID:19687206; http://dx.doi.org/10.1128/IAI.00223-09
25. Lupetti A, de Boer MG, Erba P, Campa M, Nibbering PH. Radiotracers for fungal infection imaging. Med Mycol 2011; 49(Suppl 1):S62-S69; PMID:20795767; http://dx.doi.org/10.3109/13693786.2010.508188